THE WOODLANDS, Texas, May 13, 2020 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today additional data on XERMELO’s ® (telotristat ethyl) antiproliferative effects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results